Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1985 Oct;62:95–99. doi: 10.1289/ehp.856295

Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies.

R M Santella, L L Hsieh, C D Lin, S Viet, I B Weinstein
PMCID: PMC1568684  PMID: 4085452

Abstract

It is now possible to quantitate carcinogen adducts on DNA by highly sensitive immunoassays. These techniques are particularly useful for screening human populations for exposure to potential environmental carcinogens. We have developed a panel of monoclonal antibodies that react with benzo(a)pyrene (BP) modified DNA to be used in an enzyme linked immunoassay (ELISA) to quantitate adduct levels of both human and animal samples. BALBc/Cr mice were immunized with either DNA modified by 7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9, 10-tetrahydrobenzo(a)pyrene (BPDE-I-DNA) complexed electrostatically to methylated bovine serum albumin or with BPDE-I-modified guanosine conjugated with bovine serum albumin (BPDE-I-G-BSA). Four stable clones were produced from the spleen cells of animals immunized with BPDE-I-DNA and one from BPDE-I-G-BSA immunized animals. All antibodies were shown to be highly specific for BPDE-I-DNA and did not crossreact with nonmodified DNA or with N-2-acetylaminofluorene or 1-aminopyrene modified DNA. The antibodies differed in their sensitivity to BPDE-II-DNA, BPDE-I-poly G, BPDE-I-tetraols and BPDE-I-dG. In general, all the antibodies showed the greatest affinity for their original antigen. Those generated against modified DNA showed highest reactivity against modified DNA while the one antibody generated against the monoadduct showed highest reactivity with the monoadduct. These antibodies are currently being used in a highly sensitive competitive ELISA to quantitate levels of BP-DNA adducts in various animal and human tissue samples.

Full text

PDF
95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972 Jul;109(1):129–135. [PubMed] [Google Scholar]
  2. Groopman J. D., Haugen A., Goodrich G. R., Wogan G. N., Harris C. C. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Cancer Res. 1982 Aug;42(8):3120–3124. [PubMed] [Google Scholar]
  3. Haugen A., Groopman J. D., Hsu I. C., Goodrich G. R., Wogan G. N., Harris C. C. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4124–4127. doi: 10.1073/pnas.78.7.4124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hertzog P. J., Smith J. R., Garner R. C. Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin B1DNA, the persistent DNA adduct in vivo. Carcinogenesis. 1982;3(7):825–828. doi: 10.1093/carcin/3.7.825. [DOI] [PubMed] [Google Scholar]
  5. Hsu I. C., Poirier M. C., Yuspa S. H., Grunberger D., Weinstein I. B., Yolken R. H., Harris C. C. Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res. 1981 Mar;41(3):1091–1095. [PubMed] [Google Scholar]
  6. Ivanovic V., Geacintov N. E., Yamasaki H., Weinstein I. B. DNA and RNA adducts formed in hamster embryo cell cultures exposed to benzo[a]pyrene. Biochemistry. 1978 May 2;17(9):1597–1603. doi: 10.1021/bi00602a003. [DOI] [PubMed] [Google Scholar]
  7. Jeffrey A. M., Weinstein I. B., Jennette K. W., Grzeskowiak K., Nakanishi K., Harvey R. G., Autrup H., Harris C. Structures of benzo(a)pyrene--nucleic acid adducts formed in human and bovine bronchial explants. Nature. 1977 Sep 22;269(5626):348–350. doi: 10.1038/269348a0. [DOI] [PubMed] [Google Scholar]
  8. Jennette K. W., Jeffrey A. M., Blobstein S. H., Beland F. A., Harvey R. G., Weinstein I. B. Nucleoside adducts from the in vitro reaction of benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide or benzo[a]pyrene 4,5-oxide with nucleic acids. Biochemistry. 1977 Mar 8;16(5):932–938. doi: 10.1021/bi00624a019. [DOI] [PubMed] [Google Scholar]
  9. Koreeda M., Moore P. D., Wislocki P. G., Levin W., Yagi H., Jerina D. M. Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science. 1978 Feb 17;199(4330):778–781. doi: 10.1126/science.622566. [DOI] [PubMed] [Google Scholar]
  10. Leng M., Sage E., Fuchs R. P., Duane M. P. Antibodies to DNA modified by the carcinogen N-acetoxy-N-2-acetylaminofluorene. FEBS Lett. 1978 Aug 15;92(2):207–210. doi: 10.1016/0014-5793(78)80755-8. [DOI] [PubMed] [Google Scholar]
  11. Müller R., Rajewsky M. F. Immunological quantification by high-affinity antibodies of O6-ethyldeoxyguanosine in DNA exposed to N-ethyl-N-nitrosourea. Cancer Res. 1980 Mar;40(3):887–896. [PubMed] [Google Scholar]
  12. Perera F. P., Poirier M. C., Yuspa S. H., Nakayama J., Jaretzki A., Curnen M. M., Knowles D. M., Weinstein I. B. A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. Carcinogenesis. 1982;3(12):1405–1410. doi: 10.1093/carcin/3.12.1405. [DOI] [PubMed] [Google Scholar]
  13. Poirier M. C. Antibodies to carcinogen-DNA adducts. J Natl Cancer Inst. 1981 Sep;67(3):515–519. [PubMed] [Google Scholar]
  14. Poirier M. C., Lippard S. J., Zwelling L. A., Ushay H. M., Kerrigan D., Thill C. C., Santella R. M., Grunberger D., Yuspa S. H. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6443–6447. doi: 10.1073/pnas.79.21.6443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Poirier M. C., Santella R., Weinstein I. B., Grunberger D., Yuspa S. H. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res. 1980 Feb;40(2):412–416. [PubMed] [Google Scholar]
  16. Poirier M. C., Yuspa S. H., Weinstein I. B., Blobstein S. Detection of carcinogen-DNA adducts by radiommunoassay. Nature. 1977 Nov 10;270(5633):186–188. doi: 10.1038/270186a0. [DOI] [PubMed] [Google Scholar]
  17. Santella R. M., Lin C. D., Cleveland W. L., Weinstein I. B. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. Carcinogenesis. 1984 Mar;5(3):373–377. doi: 10.1093/carcin/5.3.373. [DOI] [PubMed] [Google Scholar]
  18. Shinohara K., Cerutti P. A. Excision repair of benzo[a]pyrene-deoxyguanosine adducts in baby hamster kidney 21/C13 cells and in secondary mouse embryo fibroblasts C57BL/6J. Proc Natl Acad Sci U S A. 1977 Mar;74(3):979–983. doi: 10.1073/pnas.74.3.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Strickland P. T., Boyle J. M. Characterisation of two monoclonal antibodies specific for dimerised and non-dimerised adjacent thymidines in single stranded DNA. Photochem Photobiol. 1981 Nov;34(5):595–601. [PubMed] [Google Scholar]
  20. Van Der Laken C. J., Hagenaars A. M., Hermsen G., Kriek E., Kuipers A. J., Nagel J., Scherer E., Welling M. Measurement of O6-ethyldeoxyguanosine and N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene in DNA by high-sensitive enzyme immunoassays. Carcinogenesis. 1982;3(5):569–572. doi: 10.1093/carcin/3.5.569. [DOI] [PubMed] [Google Scholar]
  21. Wild C. P., Smart G., Saffhill R., Boyle J. M. Radioimmunoassay of O6-methyldeoxyguanosine in DNA of cells alkylated in vitro and in vivo. Carcinogenesis. 1983 Dec;4(12):1605–1609. doi: 10.1093/carcin/4.12.1605. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES